Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Adverum Biotechnologies, Inc. (ADVM)
|
Add to portfolio |
|
|
|
| Price: |
$9.02
| | Metrics |
| OS: |
101.0
|
M
| |
|
|
| Market cap: |
$911
|
M
| |
|
|
|
Net cash:
|
$141
|
M
| |
$1.40
|
per share
|
|
EV:
|
$770
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 7.5 | 0.0 | 0.3 | 1.6 | 63.1 | 1.5 | 2.3 | 0.6 |
| Revenue growth | | -100.0% | -84.5% | -97.4% | 4237.1% | -37.3% | 305.4% | 19.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.6 | -50.4 | 0.0 |
| Gross profit | 7.5 | 0.0 | 0.3 | 1.6 | 62.6 | 0.9 | 52.7 | 0.6 |
| Gross margin | 100.0% | | 100.0% | 100.0% | 99.2% | 58.8% | 2271.6% | 100.0% |
| Research and development | 89.2 | 73.3 | 40.4 | 50.1 | 39.9 | 31.7 | 25.7 | 17.0 |
| General and administrative | 64.4 | 44.6 | 28.4 | 24.6 | 20.9 | 24.4 | 22.1 | 8.0 |
| EBIT | -146.1 | -118.0 | -68.5 | -73.1 | -58.8 | -54.6 | -45.3 | -24.4 |
| EBIT margin | -1948.3% | | -27418.0% | -4533.6% | -93.3% | -3750.5% | -1951.3% | -4266.1% |
| Pre-tax income | -145.5 | -116.4 | -64.5 | -73.9 | -56.1 | -114.5 | -47.5 | -25.4 |
| Income taxes | 0.0 | 1.1 | 0.0 | -1.3 | 0.0 | -0.8 | 0.0 | 0.0 |
| Tax rate | 0.0% | | 0.0% | 1.7% | 0.0% | 0.7% | 0.0% | 0.0% |
| Net income | -145.5 | -117.5 | -64.5 | -72.6 | -56.1 | -113.7 | -47.5 | -28.6 |
| Net margin | -1940.5% | | -25794.4% | -4505.4% | -89.0% | -7817.7% | -2046.3% | -5005.9% |
| |
| Diluted EPS | ($1.48) | ($1.38) | ($1.01) | ($1.18) | ($1.29) | ($3.14) | ($1.86) | ($2.46) |
| Shares outstanding (diluted) | 98.0 | 85.1 | 64.1 | 61.4 | 43.7 | 36.2 | 25.5 | 11.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|